LABU Holdings Information

LABU is an equity ETF with a total of 149 individual holdings.

Total Holdings

Top 10 Percentage

97.62%

Asset Class

Equity

ETF Category

Trading--Leveraged Equity

Assets

758.11M

PE Ratio

n/a

Sector Allocation

No.	Symbol	Name	% Weight	Shares
1	n/a	S&P Biotechnology Select Industry Index Swap	29.49%	73,635
2	n/a	Dreyfus Govt Cash Man Ins	13.86%	111,174,506
3	n/a	Goldman Sachs Fin Gov 465 Institut	12.19%	97,727,735
4	n/a	Goldman Finl Sq Trsry Inst 506	10.94%	87,751,617
5	n/a	S&P Biotechnology Select Industry Index Swap	10.65%	25,717
6	n/a	Cash	7.03%	56,390,889
7	n/a	S&P Biotechnology Select Industry Index Swap	6.73%	20,845
8	n/a	S&P Biotechnology Select Industry Index Swap	3.02%	30,022
9	EXAS	Exact Sciences Corporation	1.88%	149,125
10	n/a	S&P Biotechnology Select Industry Index Swap	1.82%	7,315
11	RVMD	Revolution Medicines, Inc.	1.71%	182,478
12	RNA	Avidity Biosciences, Inc.	1.57%	176,026
13	INSM	Insmed Incorporated	1.44%	55,966
14	NTRA	Natera, Inc.	1.42%	48,106
15	BBIO	BridgeBio Pharma, Inc.	1.37%	154,222
16	REGN	Regeneron Pharmaceuticals, Inc.	1.36%	14,693
17	MDGL	Madrigal Pharmaceuticals, Inc.	1.36%	18,990
18	IONS	Ionis Pharmaceuticals, Inc.	1.29%	127,619
19	BIIB	Biogen Inc.	1.29%	57,268
20	AMGN	Amgen Inc.	1.24%	29,326
21	UTHR	United Therapeutics Corporation	1.22%	20,604
22	n/a	S&P Biotechnology Select Industry Index Swap	1.21%	14,129
23	INCY	Incyte Corporation	1.20%	94,700
24	ROIV	Roivant Sciences Ltd.	1.19%	475,318
25	EXEL	Exelixis, Inc.	1.17%	216,649

Showing 25 of 149 holdings

Subscribe to see the full list

As of Dec 2, 2025